Firefly Luciferase CD19 Knockout NALM6 Cell Line

Firefly Luciferase CD19 Knockout NALM6 Cell Line
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82168 2 vials - -

3 - 15 business days*

7,473.00€
 
Firefly Luciferase CD19 Knockout NALM6 Cell Line is a NALM6 cell line constitutively expressing... more
Product information "Firefly Luciferase CD19 Knockout NALM6 Cell Line"
Firefly Luciferase CD19 Knockout NALM6 Cell Line is a NALM6 cell line constitutively expressing Firefly (Photinus pyralis) luciferase under the control of a CMV promoter, in which CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) has been genetically removed using CRISPR/Cas9 genome editing using a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human CD19.
Keywords: CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen B4,
Supplier: BPS Bioscience
Supplier-Nr: 82168

Properties

Application: Negative control, in vitro/in vivo bioluminescence imaging, phenotype studies, CRISPR/Cas9
Species reactivity: human

Handling & Safety

Storage: Liquid nitrogen
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Firefly Luciferase CD19 Knockout NALM6 Cell Line"
Write a review
or to review a product.
Viewed